|
|
Community Health Systems Inc (CYH) |
|
|
|
Community Health Systems Inc 's Yearly Operating Income Growth 5 Years |
|
Select the Comparisons :
|
|
Select the Ratio:
|
Annual Operating Income Annual Growth Rates Y/Y▼
|
Annual Operating Income Annual Growth Rates Y/Y▼
|
CYH Annual Operating Income Growth |
2022
|
2021
|
2020
|
2019
|
2018
|
Y / Y Annual Operating Income Change |
-41.44 % |
24.51 % |
73.23 % |
212.5 % |
- |
Annual Operating Income (in millions $) |
$821.00 |
$1,402.00 |
$1,126.00 |
$650.00 |
$208.00 |
Annual Operating Income Growth
Comment |
Community Health Systems Inc experienced detoriation of Annual Operating Income for the fiscal year ended 2022 by -41.44% to $ 821.00 millions, compare to $ 1,402.00 in Annual Operating Income reported in the previous year. The decline in company's annual Operating Income accelerated, from the 24.51 % gain, in the fiscal year ended 2021.
Community Health Systems Inc Annual Income Statement
|
You need to upgrade your Flash Player
|
Companies with similar 2022 Annual Operating Income within Healthcare Sector | Y/Y Operating Income Growth % | 2022 Annual Operating Income | Gilead Sciences Inc | -26.09 % | $ 7,330.000 millions | Regeneron Pharmaceuticals Inc | -47.03 % | $ 4,738.900 millions | 3m Company | -11.26 % | $ 6,539.000 millions | Eli Lilly And Company | 12.12 % | $ 7,127.300 millions | Select Medical Holdings Corp | -93.50 % | $ 403.283 millions | Gsk Plc | 3.74 % | $ 6,433.000 millions | Medtronic Plc | 28.28 % | $ 5,752.000 millions | Tenet Healthcare Corp | -18.74 % | $ 2,333.000 millions | Biogen Inc | 22.63 % | $ 3,483.600 millions | Becton Dickinson And Company | -18.47 % | $ 2,282.000 millions | Vertex Pharmaceuticals Inc | 54.83 % | $ 4,307.400 millions | Zoetis Inc | 5.69 % | $ 2,917.000 millions | Stryker Corp | 9.95 % | $ 2,841.000 millions | Hologic Inc | -33.87 % | $ 1,640.200 millions | Acadia Healthcare Company Inc | 6.92 % | $ 2,427.762 millions | Fresenius Medical Care Ag | -18.38 % | $ 1,693.166 millions | Intuitive Surgical Inc | -13.39 % | $ 1,577.100 millions | Organon and Co | 12.89 % | $ 2,041.000 millions | Teva Pharmaceutical Industries Limited | | | |